Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-02

FDA Approved: NUZYRA — Original Application (Paratek Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA granted original approval for Nuzyra (omadacycline) by Paratek Pharmaceuticals for two indications: acute bacterial skin and skin structure infections a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nuzyra (Omadacycline)

Snippet

ORIG AP for NUZYRA (OMADACYCLINE)